MMR News and Research

RSS

Raising age limit for routine genetic testing in colorectal cancer could identify more cases of Lynch syndrome

Raising the age limit for routine genetic testing in colorectal cancer could identify more cases of families affected by Lynch syndrome, a condition that accounts for around 5% of all colon cancers, according to new research to be presented at the annual conference of the European Society of Human Genetics today (Monday).

29 May 2017

Northwestern Memorial first in Illinois to integrate combined MR-PET scanner into health care system

Northwestern Memorial Hospital is now home to the Chicago area's first combined magnetic resonance and positron emission tomography scanner, a machine that shortens the total time a patient spends in imaging tests while providing exceptional image quality at lower doses of radiation.

31 Mar 2017

Study: More than ten million lives saved by discovery of cell strain in 1962

Nearly 200 million cases of polio, measles, mumps, rubella, varicella, adenovirus, rabies and hepatitis A -- and approximately 450,000 deaths from these diseases -- were prevented in the U.S. alone between 1963 and 2015 by vaccination, researchers estimate.

3 Mar 2017

Most Americans believe preventive health benefits of childhood vaccines outweigh risks

Despite debate about the safety of childhood vaccines among some groups in the public, an overwhelming majority of Americans (82%) support requiring children attending public school to be vaccinated for measles, mumps and rubella (MMR), according to a new Pew Research Center survey.

2 Feb 2017

Texas A&M specialist explains what people need to know about mumps

Mumps may seem like a contagion relegated to history books, but like many other diseases of the past now preventable with a vaccine, mumps has been making a resurgence.

20 Dec 2016

Testing for Lynch syndrome: an interview with Kevin Monahan

Lynch syndrome is an inherited condition which causes about 1,100 cases of bowel cancer and 1,000 other cancers annually in the UK. It is caused by a fault in the mismatch repair gene (MMR) which usually works to prevent cancer.

21 Nov 2016

Vaccine-related rubella virus causes harm in some patients with primary immunodeficiency disorders

Some patients with rare primary immunodeficiency disorders may be at risk for infection by rubella virus, and possibly serious skin inflammation, after receiving the rubella vaccine, usually administered as part of the measles-mumps-rubella (MMR) vaccine.

7 Nov 2016

Measles complication that kills children more common than previously thought

A complication of measles that kills children years after they have the infection is more common than thought, according to a study being presented at IDWeek 2016.

31 Oct 2016

Super-Resolution Imaging of Biological Specimens

In this interview, News Medical speaks to Dr. Manasa Gudheti of Bruker Nano Surfaces about biological specimens and how to acquire super-resolution images of them.

From Bruker Nano Surfaces and Metrology 27 Sep 2016

SINAPSE network enhances strengths to develop world-class future in medical imaging for Scotland

Scotland has a strong legacy as one of the pioneers of medical imaging. In the late 70s, Aberdeen University became the first institution to develop a full body MRI scanner; the system named the Mark I prototype was an enormous step forward for healthcare.

21 Sep 2016

SLU to conduct human clinical trial of vaccine to protect people from Zika virus

Saint Louis University's vaccine center has been tapped by the National Institutes of Health to conduct a human clinical trial of a vaccine to prevent the Zika virus, which can cause devastating birth defects in babies.

24 Jun 2016

Long-term dasatinib findings support first-line use in CML

Final DASISION study findings confirm dasatinib to be an effective, long-term treatment for patients with a new diagnosis of chronic phase-chronic myeloid leukaemia.

15 Jun 2016

EPIC Results Shed Light On First-Line Ponatinib Risk-Benefit Profile

The primary endpoint of major molecular response at 12 months for ponatinib versus imatinib in patients with newly diagnosed chronic phase-chronic myeloid leukaemia remains undetermined, report the EPIC trial investigators.

18 May 2016

CML treatment-free remission criteria outlined

Treatment-free remission may be feasible in many patients with chronic myeloid leukaemia, say researchers who set out clinical and logistical requirements for discontinuing tyrosine kinase inhibitor therapy.

18 May 2016

Doctor’s access to vaccination data can improve pediatric immunization coverage

Exchange of immunization data between a centralized city immunization registry and provider electronic health records led to significant improvements in pediatric immunization coverage, a reduction in over-immunization for adolescents, and increased completeness of immunization records, according to a study conducted at Columbia University's Mailman School of Public Health, Columbia University Medical Center, NewYork-Presbyterian, and the New York City Department of Health and Mental Hygiene's Citywide Immunization Registry.

6 May 2016

Pre-TKI cytokine profiling predicts CP-CML outcome

Measuring levels of transforming growth factor-α and interleukin-6 may help identify patients with newly diagnosed chronic phase-chronic myeloid leukaemia at risk of a poor outcome from tyrosine kinase inhibitor therapy, research suggests.

20 Apr 2016

Additional chromosomal abnormalities prognostic for CML

Additional chromosomal abnormalities can be used to create two prognostic groups of patients with chronic myeloid leukaemia, suggests research published in Blood.

20 Apr 2016

Siemens Healthcare launches new MR applications to help hospitals reduce scan times in neurology

Siemens Healthcare has launched a range of new MR applications to help hospitals reduce the time needed for MR imaging within neurology. It is estimated that 20 to 25 per cent of all MR examinations are neurological, with the number expected to grow in 2016.

17 Mar 2016

Real-life data show feasibility of imatinib discontinuation in CML

Italian research shows that long-term imatinib discontinuation is feasible outside of a clinical trial setting for patients with chronic myeloid leukaemia who achieve stable undetectable molecular disease with front-line treatment.

17 Mar 2016

Preventing the spread of Zika: an interview with Professor John Oxford

The link between the Zika virus and Guillain-Barré on the one hand, and pregnancy and the virus affecting the fetus in terms of microcephaly on the other, is still not confirmed conclusively.

1 Mar 2016